Maker of Alzheimer drug Leqembi expects FDA’s full approval this summer

Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this s...

The Scandal Of Alzheimer’s

Why is there no cure for Alzheimer’s—or why aren’t there medications that can at least substantially slow or meaningfully ameliorate the disease? It afflicts more than 6 million Americans, with that n...

Cinnamon Improves Your Memory And Cognition

A new review of the scientific literature finds evidence to support the role of cinnamon and several of its bioactive compounds in preserving brain function and in slowing cognitive impairment associa...

Antioxidant-Rich Foods—Like Kale, Tea, Broccoli—Could Slow Rate Of Memory Decline, Study Suggests

Topline People who eat or drink foods with antioxidant flavonols could experience a slower rate of memory decline, according to a study published in the medical journal Neurology Tuesday, as an estima...

Dementia May Lead To Greater Risk Of Covid Death Than Previously Thought, Study Suggests

Topline Conditions like Alzheimer’s and dementia may put patients at an even greater risk of death from Covid-19 than heart disease and other ailments thought to be the most dangerous, according to a ...